Arcitumomab is a monoclonal antibody that is primarily used in the medical field for diagnostic imaging, particularly in the detection of colorectal cancer. It is a murine IgG1 antibody that specifically targets the carcinoembryonic antigen (CEA), a protein often overexpressed in various cancers. Arcitumomab is labeled with a radioactive isotope, allowing it to be used in radioimmunoscintigraphy, a technique that helps visualize tumors in the body through imaging technologies. The substance is characterized by its specificity for CEA, which enhances its utility in distinguishing malignant tissues from normal tissues. Its use is generally associated with minimal side effects, as it is designed to bind selectively to cancer cells. However, as with any therapeutic agent, patient-specific factors and the context of use can influence its effectiveness and safety profile. Overall, Arcitumomab represents a significant advancement in the field of cancer diagnostics, providing valuable information for treatment planning and monitoring.

Arcitumomab

154361-48-5: Arcitumomab is a monoclonal antibody that is primarily used in the medical field for diagnostic imaging, particularly in the detection of colorectal cancer. It is a murine IgG1 antibody that specifically targets the carcinoembryonic antigen (CEA), a protein often overexpressed in various cancers. Arcitumomab is labeled with a radioactive isotope, allowing it to be used in radioimmunoscintigraphy, a technique that helps visualize tumors in the body through imaging technologies. The substance is characterized by its specificity for CEA, which enhances its utility in distinguishing malignant tissues from normal tissues. Its use is generally associated with minimal side effects, as it is designed to bind selectively to cancer cells. However, as with any therapeutic agent, patient-specific factors and the context of use can influence its effectiveness and safety profile. Overall, Arcitumomab represents a significant advancement in the field of cancer diagnostics, providing valuable information for treatment planning and monitoring.

A murine IgG monoclonal Fab fragment antibody targeting carcinoembryonic antigen (CEA)

CAS 154361-48-5

Arcitumomab

Arcitumomab

Ref: 3D-CLA1092